The agreement with the MRC, Imperial College London, King’s College London and University College London will see the new joint venture take control of operations at GlaxoSmithKline’s clinical imaging centre in the capital.
Operations and staff at the facility – which is located on Imperial College London’s Hammersmith Hospital campus – will be transferred to the new venture in the third quarter of 2011 to conduct research into new areas and applications of imaging.
It is thought that this new public-private partnership model will create the UK’s leading medical imaging centre and will assist in the translation of clinical research into healthcare benefits.
Dr Patrick Vallance, head of medicines discovery and development at GlaxoSmithKline, said: “This agreement is further evidence of the industry shifting towards a more open model of working.”
Last month, the company announced plans to conduct a programme of educational events in the lead-up to the 2012 Olympic Games that will aim to encourage British students to pursue science careers.
http://www.zenopa.com/news/800497778/GlaxoSmithKline_agrees_new_UK_clinical_imaging_collaboration
Adalbert-Stifter-Weg 2 b
85661 Forstinning
Germany
Tel.: +49 1511 15674833